JP2024073525A5 - - Google Patents

Download PDF

Info

Publication number
JP2024073525A5
JP2024073525A5 JP2024037853A JP2024037853A JP2024073525A5 JP 2024073525 A5 JP2024073525 A5 JP 2024073525A5 JP 2024037853 A JP2024037853 A JP 2024037853A JP 2024037853 A JP2024037853 A JP 2024037853A JP 2024073525 A5 JP2024073525 A5 JP 2024073525A5
Authority
JP
Japan
Prior art keywords
nucleic acid
composition
acid molecule
mir
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024037853A
Other languages
English (en)
Japanese (ja)
Other versions
JP7893574B2 (ja
JP2024073525A (ja
Filing date
Publication date
Priority claimed from PCT/EP2019/074056 external-priority patent/WO2020053186A1/en
Application filed filed Critical
Publication of JP2024073525A publication Critical patent/JP2024073525A/ja
Publication of JP2024073525A5 publication Critical patent/JP2024073525A5/ja
Priority to JP2026044222A priority Critical patent/JP2026091891A/ja
Application granted granted Critical
Publication of JP7893574B2 publication Critical patent/JP7893574B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024037853A 2018-09-11 2024-03-12 代謝性疾患の処置において使用するためのマイクロrnaインヒビター Active JP7893574B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026044222A JP2026091891A (ja) 2018-09-11 2026-03-18 代謝性疾患の処置において使用するためのマイクロrnaインヒビター

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
LULU100927 2018-09-11
LU100927 2018-09-11
PCT/EP2019/074056 WO2020053186A1 (en) 2018-09-11 2019-09-10 Microrna inhibitors for use in treating metabolic diseases
JP2020569736A JP7530836B2 (ja) 2018-09-11 2019-09-10 代謝性疾患の処置において使用するためのマイクロrnaインヒビター

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020569736A Division JP7530836B2 (ja) 2018-09-11 2019-09-10 代謝性疾患の処置において使用するためのマイクロrnaインヒビター

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026044222A Division JP2026091891A (ja) 2018-09-11 2026-03-18 代謝性疾患の処置において使用するためのマイクロrnaインヒビター

Publications (3)

Publication Number Publication Date
JP2024073525A JP2024073525A (ja) 2024-05-29
JP2024073525A5 true JP2024073525A5 (cg-RX-API-DMAC10.html) 2024-09-25
JP7893574B2 JP7893574B2 (ja) 2026-07-22

Family

ID=63998726

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020569736A Active JP7530836B2 (ja) 2018-09-11 2019-09-10 代謝性疾患の処置において使用するためのマイクロrnaインヒビター
JP2024037853A Active JP7893574B2 (ja) 2018-09-11 2024-03-12 代謝性疾患の処置において使用するためのマイクロrnaインヒビター
JP2026044222A Pending JP2026091891A (ja) 2018-09-11 2026-03-18 代謝性疾患の処置において使用するためのマイクロrnaインヒビター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020569736A Active JP7530836B2 (ja) 2018-09-11 2019-09-10 代謝性疾患の処置において使用するためのマイクロrnaインヒビター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026044222A Pending JP2026091891A (ja) 2018-09-11 2026-03-18 代謝性疾患の処置において使用するためのマイクロrnaインヒビター

Country Status (7)

Country Link
US (1) US12584126B2 (cg-RX-API-DMAC10.html)
EP (1) EP3850099B1 (cg-RX-API-DMAC10.html)
JP (3) JP7530836B2 (cg-RX-API-DMAC10.html)
CN (1) CN112654705B (cg-RX-API-DMAC10.html)
CA (1) CA3103175A1 (cg-RX-API-DMAC10.html)
DK (1) DK3850099T3 (cg-RX-API-DMAC10.html)
WO (1) WO2020053186A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7530836B2 (ja) 2018-09-11 2024-08-08 ヘルムホルツ・ツェントルム・ミュンヘン・ドイチェス・フォーシュンクスツェントルム・フュア・ゲズントハイト・ウント・ウンベルト・ゲーエムベーハー 代謝性疾患の処置において使用するためのマイクロrnaインヒビター
CN111228291B (zh) * 2020-03-20 2020-10-02 军事科学院军事医学研究院环境医学与作业医学研究所 miR-541在制备抗神经元细胞缺氧损伤药物中的应用及药物
CN121818694B (zh) * 2025-12-23 2026-07-28 内蒙古大学 改善胰岛素抵抗的miR-3963在制备药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US5792608A (en) 1991-12-12 1998-08-11 Gilead Sciences, Inc. Nuclease stable and binding competent oligomers and methods for their use
US5525711A (en) 1994-05-18 1996-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pteridine nucleotide analogs as fluorescent DNA probes
WO2014074874A1 (en) * 2012-11-09 2014-05-15 Regents Of The University Of Minnesota Osteosarcoma diagnostic and prognostic methods
EP2868746A1 (en) 2013-10-29 2015-05-06 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Micrornas modulating the effect of glucocorticoid signaling
WO2016065001A1 (en) * 2014-10-21 2016-04-28 University Of Massachusetts Recombinant aav variants and uses thereof
CN106267207A (zh) * 2015-06-05 2017-01-04 昆山彭济凯丰生物科技有限公司 通过miR-96进行减肥、降血糖和降血脂的方法和药物及其应用
WO2019102268A1 (en) * 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
JP7530836B2 (ja) 2018-09-11 2024-08-08 ヘルムホルツ・ツェントルム・ミュンヘン・ドイチェス・フォーシュンクスツェントルム・フュア・ゲズントハイト・ウント・ウンベルト・ゲーエムベーハー 代謝性疾患の処置において使用するためのマイクロrnaインヒビター

Similar Documents

Publication Publication Date Title
US20140066491A1 (en) Chemical modification motifs for mirna inhibitors and mimetics
JP2005517427A5 (cg-RX-API-DMAC10.html)
JP2005517438A5 (cg-RX-API-DMAC10.html)
AU2019234917B2 (en) Inhibitors of micro-RNA 22
JP2024531728A5 (cg-RX-API-DMAC10.html)
JP2024112834A5 (cg-RX-API-DMAC10.html)
JP2009535039A5 (cg-RX-API-DMAC10.html)
KR20250125967A (ko) 진보된 rna 표적화 (arnatar)
US20240336919A1 (en) Rna editing
JP2023542889A5 (cg-RX-API-DMAC10.html)
JP2022522166A5 (cg-RX-API-DMAC10.html)
JP2020503014A5 (cg-RX-API-DMAC10.html)
JP7793144B2 (ja) 修飾ヘテロ核酸
CN112654705B (zh) 用在治疗代谢疾病中的微小rna抑制剂
JP2024522272A5 (cg-RX-API-DMAC10.html)
US20220135972A1 (en) Optimal ps modification pattern for heteronucleic acids
Dysko et al. Covalently attached intercalators restore duplex stability and splice-switching activity to triazole-modified oligonucleotides
JP2022546408A5 (cg-RX-API-DMAC10.html)
US20250297253A1 (en) Artificial rna molecule
EP4709862A2 (en) Rnai targeting kif1a missense mutations for treatment of kif1a associated neurological disorder
JP2025518522A5 (cg-RX-API-DMAC10.html)
JP2022508835A5 (cg-RX-API-DMAC10.html)
CN115702243A (zh) 用于治疗性多核苷酸的鸟苷类似物
WO2024186922A2 (en) Compositions and methods for cell-type specific activation of therapeutic nucleic acids
HK40111119A (en) Oligonucleotide gba agonists